Healthcare >> CEO Interviews >> February 23, 2009

John Thievon & David Becker – Middlebrook Pharmaceuticals, Inc. (mbrk)

JOHN THIEVON has served as President, Chief Executive Officer and a Director of MiddleBrook Pharmaceuticals, Inc., since September 2008. Prior to joining MiddleBrook, from January 1999 to February 2008, he held various positions at Adams Respiratory Therapeutics, Inc., including Executive Vice President, Sales and Corporate Accounts from July 2007 to February 2008; Executive Vice President, Sales and Business Development from October 2006 to June 2007; Executive Vice President, Commercial Operations from May 2005 to October 2006; Vice President, Sales and Professional Marketing from 2000 to May 2005; and from January 1999 to May 2000, he held various positions with Adams, including Northeast Regional Business Director and Director of Marketing. From January 1995 to December 1998, he held various positions with IMS Health Incorporated, including Account Manager, Account Director, and Director of Sales Training, and from 1990 to 1994, he served as a Sales Representative with Ortho Pharmaceuticals Inc. Mr. Thievon has been a member of DaySpring Pharma, LLC's Board of Directors since November 2007. DaySpring is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription and non-prescription products for specialty markets in women's health and pediatrics. He graduated from Pace University with a Bachelor of Business Administration degree, with a concentration in Marketing. Profile
DAVID BECKER has been Executive Vice President and Chief Financial Officer at MiddleBrook Pharmaceuticals, Inc., since September 2008. Prior to joining MiddleBrook, he served as an independent consultant to various healthcare companies from March 2007 to June 2008, providing them with Chief Financial Officer and/or Chief Executive Officer services. In addition, Mr. Becker sat on the Board of Directors for several of these healthcare companies. From 2000 to 2007, he served as the Chief Financial Officer and Treasurer of Adams Respiratory Therapeutics, Inc., and served in various other capacities with Adams over that period, including Chief Financial and Administrative Officer from October 2006 to February 2007, and interim Chief Operating Officer from May 2003 to April 2004. Prior to joining Adams, Mr. Becker was a senior manager in the merger and acquisitions practice of Ernst & Young LLP from November 1997 to September 2000. From January 1996 to November 1997, Mr. Becker served as Controller for the Salt Lake City-based startup company RxAmerica LLC, a pharmacy benefit management and mail-service pharmacy operation. From 1991 to 1995, he served as a financial auditor with Ernst & Young LLP. Mr. Becker began his professional career in 1990 as an audit and tax accountant for the Southern California-based accounting firm of Glenn M. Gelman & Associates. He earned a Bachelor's degree in Accounting in 1990 from the University of Southern Mississippi and is a Certified Public Accountant and Certified Treasury Professional. Profile
TWST: Would you begin with a brief historical sketch of MiddleBrook and a

picture of the things that the company is doing now?

Mr. Thievon: MiddleBrook Pharmaceuticals was founded in 2000 on